Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa Isolated From Combat Casualties
Open Access
- 30 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 187 (3-4), 426-434
- https://doi.org/10.1093/milmed/usab259
Abstract
Multidrug-resistant (MDR) Gram-negative infections complicate care of combat casualties. We describe the clinical characteristics, resistance patterns, and outcomes of Pseudomonas aeruginosa infections in combat casualties. Combat casualties included in the Trauma Infectious Disease Outcomes Study with infections with and without P. aeruginosa isolation during initial hospitalization were compared. Pseudomonas aeruginosa from initial wound, blood, and serial isolates (≥7 days from previous isolate) collected from June 2009 through February 2014 was subjected to antimicrobial susceptibility testing, pulsed-field gel electrophoresis, and whole genome sequencing for assessing clonality. Multidrug resistance was determined using the CDC National Healthcare Safety Network definition. Of 829 combat casualties with infections diagnosed during initial hospitalization, 143 (17%) had P. aeruginosa isolated. Those with P. aeruginosa were more severely injured (median Injury Severity Score 33 [interquartile range (IQR) 27-45] vs 30 [IQR 18.5-42]; P < .001), had longer hospitalizations (median 58.5 [IQR 43-95] vs 38 [IQR 26-56] days; P < .001), and higher mortality (6.9% vs 1.5%; P < .001) than those with other organisms. Thirty-nine patients had serial P. aeruginosa isolation (median 2 subsequent isolates; IQR: 1-5), with decreasing antimicrobial susceptibility. Ten percent of P. aeruginosa isolates were MDR, associated with prior exposure to antipseudomonal antibiotics (P = .002), with amikacin and colistin remaining the most effective antimicrobials. Novel antimicrobials targeting MDR Gram-negative organisms were also examined, and 100% of the MDR P. aeruginosa isolates were resistant to imipenem/relabactam, while ceftazidime/avibactam and ceftolozane/tazobactam were active against 35% and 56% of the isolates, respectively. We identified two previously unrecognized P. aeruginosa outbreaks involving 13 patients. Pseudomonas aeruginosa continues to be a major cause of morbidity, affecting severely injured combat casualties, with emergent antimicrobial resistance upon serial isolation. Among MDR P. aeruginosa, active antimicrobials remain the oldest and most toxic. Despite ongoing efforts, outbreaks are still noted, reinforcing the crucial role of antimicrobial stewardship and infection control.Keywords
Funding Information
- Infectious Disease Clinical Research Program
- Department of Defense program
- Uniformed Services University of the Health Sciences
- Department of Preventive Medicine and Biostatistics
- National Institute of Allergy and Infectious Diseases (Y1-AI-5072)
- Defense Health Program (HU0001190002)
- Military Infectious Diseases Research Program
This publication has 35 references indexed in Scilit:
- Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyDiagnostic Microbiology and Infectious Disease, 2011
- Multidrug-Resistant Bacterial Colonization of Combat-Injured Personnel at Admission to Medical Centers After Evacuation From Afghanistan and IraqJournal Of Trauma-Injury Infection and Critical Care, 2011
- Infections Complicating the Care of Combat Casualties During Operations Iraqi Freedom and Enduring FreedomJournal Of Trauma-Injury Infection and Critical Care, 2011
- Infection-Associated Clinical Outcomes in Hospitalized Medical Evacuees After Traumatic Injury: Trauma Infectious Disease Outcome StudyJournal Of Trauma-Injury Infection and Critical Care, 2011
- Multidrug-resistant Organisms in Military Wounds from Iraq and AfghanistanClinical Orthopaedics & Related Research, 2008
- Osteomyelitis in Military Personnel Wounded in Iraq and AfghanistanJournal Of Trauma-Injury Infection and Critical Care, 2008
- Trauma-related Infections in Battlefield Casualties From IraqAnnals of Surgery, 2007
- The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa InfectionsDrugs, 2007
- Acquisition of Multidrug‐ResistantPseudomonas aeruginosain Patients in Intensive Care Units: Role of Antibiotics with Antipseudomonal ActivityClinical Infectious Diseases, 2004
- Viet Nam Wound AnalysisJournal Of Trauma-Injury Infection and Critical Care, 1978